Precision Optics Corporation — Q1 Fiscal 2027 Earnings Summary
Financial Performance:
- Revenue increased 22% year-over-year to $8.2 million from $6.7 million in the prior-year fiscal first quarter.
- Production revenue grew 23% to $7.4 million from $6.0 million in the prior fiscal year quarter.
- Engineering design services revenue increased 11% year-over-year to $728,000.
- Gross margin improved to 22.5% from 14.2% in the prior fiscal year first quarter.
- Net loss narrowed to $475,000 ($0.04 per share) from $1.6 million ($0.21 per share) in the prior fiscal year first quarter.
- Adjusted EBITDA was approximately $(0.2) million, compared with $(1.2) million in the prior fiscal year first quarter.
- Cash and cash equivalents were $9.0 million at September 30, 2026, down from $9.8 million at June 30, 2026.
- Total operating expenses decreased to $2,356,161 from $2,541,613 in the prior year period.
- Operating loss improved to $(518,310) from $(1,595,255) in the prior year period.
- Net cash used in operating activities was $(672,145) for the three months ended September 30, 2026, compared to net cash provided of $78,227 in the prior year period.
Guidance and Future Outlook:
- The Company maintains its fiscal year 2027 revenue expectation in the range of $30 million to $33 million.
- The Company maintains its fiscal year 2027 Adjusted EBITDA expectation in the range of $(1.2) million to $(1.7) million.
Business Segments and Product Lines:
- The established satellite optical communications program generated $2.3 million in revenue during the first quarter.
- The single-use cystoscope program generated approximately $1.8 million in production revenue during the first quarter.
- The single-use ophthalmic program generated $581,000 in revenue, with shipments increasing under a $3.5 million follow-on order.
- A follow-on engineering order was received from a U.S. space technology company developing a new satellite constellation.
- A $1.3 million follow-on production order was received from a large defense company, with production commencing in October 2026.
Market and Competitive Landscape:
- Satellite communications are becoming an increasingly key market for the Company.
- The Company serves the medical device, defense/aerospace, and satellite communications markets.
Management Commentary and Tone:
- CEO Dr. Joe Forkey stated that higher volumes and more efficient manufacturing helped lift gross margin and improve Adjusted EBITDA.
- Management noted that a $2 million follow-on production order from a top-tier aerospace customer was received earlier than anticipated.
- Management highlighted continued operational progress with single-use medical device programs.
Other Key Points:
- The Company received a follow-on production order from a top-tier aerospace customer after the quarter-end.
- Stock-based compensation expense was $229,278 for the quarter, down from $301,639 in the prior year period.
- Weighted average common shares outstanding increased to 10,974,771 from 7,714,701 in the prior year period.
- Accounts receivable decreased to $5,371,290 from $5,944,412 at the end of the prior quarter.
- Inventories decreased to $3,518,893 from $3,829,414 at the end of the prior quarter.
- Total liabilities decreased to $10,416,067 from $11,985,822 at the end of the prior quarter.
- Total stockholders' equity was $20,199,986 at September 30, 2026.
- Company
- PRECISION OPTICS CORPORATION INC
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies